Quantum Healthcare (V8Y.SI) up 100% pre-market 03 Jan 2026: monitor post-conversion volume
Quantum Healthcare Limited (V8Y.SI) stock reopened pre-market on 03 Jan 2026 at SGD 0.002 after a reported 100.0% close move linked to a completed debt conversion and directors’ fees capitalization on 31 Dec 2025. This V8Y.SI stock move followed an allotment of roughly 1.85 billion new shares to PW Dental and compressed float dynamics on the Singapore Exchange (SES). We summarise the price, liquidity and balance-sheet metrics and explain why the event matters for short-term traders and longer-term investors.
What drove the high-volume move
Quantum Healthcare Limited (V8Y.SI) reported completion of a debt conversion and capitalization of directors’ fees on 31 Dec 2025, triggering a >100.0% close move reported in market coverage and linked to an allotment of about 1,850,000,000 new shares to PW Dental. Market commentary tied the price action to the corporate restructuring rather than an earnings surprise, and the headline move is consistent with a corporate-event driven re-pricing source.
Price, volume and trading snapshot
Pre-market on 03 Jan 2026 the stock is quoted at SGD 0.002 (priceAvg50: SGD 0.00128, priceAvg200: SGD 0.00129) with reported intraday range SGD 0.002–0.002. Market capitalisation is SGD 8014501.00 based on 8,014,501,000.00 shares outstanding. Reported volume in the snapshot is 1,000.00 against an average volume of 796,403.00, leaving relative volume low compared with averages despite the headline percentage move.
Fundamentals and key ratios
On the fundamentals side the company shows constrained liquidity and negative earnings metrics: current ratio 0.25, operating cash flow per share 0.00017 and net income per share -0.00023. Price-to-sales is 0.62 and enterprise value to sales 1.13, while trailing margin metrics show net profit margin -14.17% and operating margin -11.82%. These metrics point to a small-cap medical devices and healthcare services group with stretched working capital and negative profitability in the latest TTM figures.
Technical indicators and market context
Technicals are mixed and reflect low trading depth: RSI 45.50, ADX 21.71 and CCI -106.06 indicating limited trend strength and oversold momentum on some oscillators. On SES the broader Healthcare sector has outperformed cyclicals year-to-date, but Quantum’s liquidity and micro-cap status create idiosyncratic swings and wide bid-ask spreads for active traders.
Meyka AI grade and analyst framing
Meyka AI rates V8Y.SI with a score of 38 out of 100 — Grade: D — SUGGESTION: SELL/HOLD FOR RISK MANAGED TRADERS. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics and analyst consensus. The low grade reflects negative TTM profitability, a current ratio of 0.25 and high enterprise value relative to earnings, while recognising the company’s device design and healthcare services footprint in Singapore. These grades are model outputs and not financial advice.
Risks, catalysts and near-term watch list
Key near-term catalysts are share dilution confirmation, counterparty lock-up details related to PW Dental, any further restructuring announcements and updated filings on cash position. Main risks include low free float, negative operating margins, working capital deficit and limited institutional coverage. Traders should monitor post-conversion volume and regulatory filings for changes to share class or voting rights source.
Final Thoughts
Key takeaways: Quantum Healthcare Limited (V8Y.SI) reopened pre-market on 03 Jan 2026 at SGD 0.002 after a 100.0% close move driven by a completed debt conversion and the allotment of about 1,850,000,000.00 new shares to PW Dental. The stock’s micro-cap profile shows market cap SGD 8014501.00, low reported cash per share (0.00002) and a constrained current ratio of 0.25. Meyka AI’s forecast model projects a 1-year price of SGD 0.00143, implying an estimated downside of -28.69% versus the current SGD 0.002; the model also shows a 3-year projection of SGD 0.02630 (implied +1215.04%). Those longer-run model outputs contrast with near-term liquidity and balance-sheet risks. Investors should treat short-term price moves as event-driven and confirm dilution mechanics and lock-up terms before adding exposure. Meyka AI provides this as AI-powered market analysis and model-driven scenarios; forecasts are projections and not guarantees.
FAQs
The move followed completion of a debt conversion and directors’ fees capitalization on 31 Dec 2025, with about 1,850,000,000.00 new shares allotted to PW Dental, which changed supply dynamics and caused an event-driven re-price.
Pre-market on 03 Jan 2026 the stock is quoted at SGD 0.002 and market capitalisation is SGD 8014501.00 based on 8,014,501,000.00 shares outstanding on the Singapore Exchange (SES).
Meyka AI’s forecast model projects a 1-year price of SGD 0.00143 (implied -28.69% vs SGD 0.002) and a 3-year value of SGD 0.02630. Forecasts are model-based projections and not guarantees.
Primary risks are low liquidity and float, negative margins and weak current ratio (0.25), potential further dilution, and limited analyst coverage, which can amplify price volatility for small-cap healthcare names.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
